Skip to content

Not medical advice. Talk to your provider before using any peptide. Full disclaimer

Peptide Schedule Research TeamReviewed Apr 8, 20265 Citations

Eptifibatide (Integrilin) peptide icon, one bubble per amino acidEptifibatide (Integrilin)7 residuesXKGDWPCEach bubble = one amino acid. Size = residue mass. Color = chemical class.

Eptifibatide (Integrilin) Dosage Calculator

Immune · FDA Approved · Grade B · 2.5 h half-life · Injection

Dosing protocol

Eptifibatide (Integrilin) Dosage

LevelDose / InjectionFrequency
Beginner180 mcg/kgSingle dose
Moderate180 mcg/kgSingle dose
Aggressive180 mcg/kgDouble bolus (x2, 10 min apart)

No syringe calculation for this route

Intravenous

Eptifibatide (Integrilin) has no default water volume for this calculator, so there are no syringe units to calculate here. Dosing runs 180 mcg/kg to 180 mcg/kg per administration, single dose.

This peptide is prepared by a hospital or research pharmacy and given under medical supervision. There is no home mix to calculate.

Open Eptifibatide (Integrilin) details
Side effects, protocols by goal, storage, and the sources behind these dosing numbers.

About Eptifibatide (Integrilin)

Beginner, moderate, and aggressive dosing amounts with timing. Free to use.

Eptifibatide (Integrilin) is an FDA-approved GP IIb/IIIa inhibitor given by IV during heart attacks and coronary stenting. Backed by the PURSUIT (n=10,948) and ESPRIT trials, it blocks platelet aggregation within minutes. Hospital use only, with platelet recovery in 4 to 8 hours.

AntiplateletGP IIb/IIIa InhibitorAcute Coronary SyndromePCIFDA-Approved
Intravenous. Typical beginner frequency: single dose.
Store at 2-8°C (36-46°F); protect from light. Use within 24 hours once vial is opened; do not freeze.

View side effects and safety warnings →

Quick-Start: How to Use Eptifibatide (Integrilin)

  1. 1Confirm the patient has no contraindications: no active bleeding, no stroke within 30 days, no severe uncontrolled hypertension, no thrombocytopenia below 100,000/mm3, no major surgery within 6 weeks. Obtain baseline CBC, creatinine, and calculate CrCl using Cockcroft-Gault with actual body weight.
  2. 2Calculate the bolus dose: 180 mcg/kg times actual body weight. For a 70 kg patient, that equals 12.6 mg. Draw 6.3 mL from the 2 mg/mL (10 mL) bolus vial. For an 80 kg patient: 14.4 mg, draw 7.2 mL.
  3. 3Administer the bolus as IV push over 1 to 2 minutes through a dedicated line or compatible Y-site (normal saline or D5W).
Full usage guide →

Eptifibatide (Integrilin) Dosing Protocol

FDA LabelINTEGRILIN (eptifibatide) FDA Prescribing Information (2021)
LevelDose / InjectionFrequency
Beginner180 mcg/kgSingle dose
Moderate180 mcg/kgSingle dose
Aggressive180 mcg/kgDouble bolus (x2, 10 min apart)
Note:

Eptifibatide comes ready to use. No reconstitution needed. Two vial concentrations exist: 2 mg/mL in a 10 mL bolus vial (20 mg total) and 0.75 mg/mL in a 100 mL infusion vial (75 mg total). Mixing up the two vials is a recognized medication error.

For the weight-based math on a 70 kg patient: 180 mcg/kg equals 12,600 mcg (12.6 mg). From the 2 mg/mL bolus vial, that's 6.3 mL. The continuous infusion at 2 mcg/kg/min equals 140 mcg/min, which is 8.4 mg/h. From the 100 mL infusion vial (0.75 mg/mL), the rate comes to 11.2 mL/h.

The mistake that trips up cath lab teams most often is flat-dosing instead of weight-based dosing. Writing "180 mcg" instead of "180 mcg/kg" underdoses by a factor of 70. Always confirm the calculation: dose equals the per-kg value times actual body weight in kilograms; use actual weight, not ideal. Store vials at 2 to 8 degrees Celsius, protected from light. Don't freeze. Use opened vials within 24 hours.

Dosing based on INTEGRILIN (eptifibatide) FDA Prescribing Information (2021): 5 published references.View all sources →

Ask AI about this math

Cross-check your Eptifibatide (Integrilin) reconstitution math with AI

Eptifibatide (Integrilin) Cost

Brand Price
INTEGRILIN (GSK/Schering-Plough, now generic only): original brand no longer marketed as branded product in US. Generic eptifibatide has fully replaced branded Integrilin.
Generic / Research
Generic eptifibatide: 10 mL vial (2 mg/mL, 20 mg) approximately $35–80/vial; 100 mL vial (0.75 mg/mL, 75 mg) approximately $130–300/vial. Hospital acquisition costs are substantially lower via group purchasing organization (GPO) contracts. Billed to payer as inpatient procedure cost: J-code J1327 (eptifibatide injection, 5 mcg) used for outpatient buy-and-bill billing.
Compounded
Not applicable: eptifibatide is a pharmaceutical-grade IV solution; compounding is not part of the clinical use pathway and would not be appropriate given FDA-approved product availability.

Pricing updated 2026-04-09

Prices are estimates and vary by source, location, and prescription status.Full pricing breakdown →

Eptifibatide (Integrilin) Pharmacokinetics

Pharmacokinetics: Active Dose Over Time

t½ = ~2.5 hours
50%25%12.5%100%75%50%25%0%03h5h8h10h13hTime after injectionDose remaining
After 1 half-life (3h): 50% remainsAfter 2 half-lives (5h): 25% remainsAfter 3 half-lives (8h): 12.5% remains
At a 180 mcg/kg dose: 50% = 90 mcg/kg remaining after 3h. Moderate-tier frequency in our sources: Single dose.

Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only, not medical advice.

Read the full Eptifibatide (Integrilin) guide →

Related Tools

Frequently Asked Questions

Store Eptifibatide (Integrilin) at 2-8°C (36-46°F); protect from light. Use within 24 hours once vial is opened; do not freeze.